Dong-A’s Management Change Not Likely to Affect Its Stock Price

From a recent announcement surrounding the key management change by Dong-A Pharmaceuticals, the market is viewing this as a positive momentum for the company, reported Kim Hee-sung, an analyst at HanYang Securities.

There has been a widely circulated rumor that there is a conflict between Kang Shin-ho, the company’s chairman, and his son, Kang Moon-seok, over an appointment of Kim Won-bae as...